Gideon Pharmaceuticals


Public lists: Pharma Startups (4733)

Gideon Pharmaceuticals' development-stage pharmaceutical products employ the patented Heprotect technology, which reduces the hepatotoxicity of hepatocellular toxic agents without interfering with bioactivity. Among the drugs being developed by Gideon are Heprotect versions of acetaminophen, methotrexate, acitretin and itraconazole, all compounds with established efficacy and side-effect profiles that include liver toxicity.

Gideon Pharmaceuticals' development-stage pharmaceutical products employ the patented Heprotect technology, which reduces the hepatotoxicity of hepatocellular toxic agents without interfering with bioactivity. Among the drugs being developed by Gideo...Show all

Company (Acquired)

Phone:

Fax:

100 Fairway Drive
Suite 134
Vernon Hills, 60061
Illinois, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Gideon Pharmaceuticals $0M Apr 15, 2016

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Gideon Pharmaceuticals Jobs

jobs by Indeed job
						search
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Compositions and method for treating affective, painful or allergic disorders Feb 17, 2009 Aug 10, 2010 Patent
Compositions and method for treating affective, painful or allergic disorders Feb 18, 2004 Dec 08, 2009 Patent